Share on

Global 3D Bioprinting Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report - Segmented By Component, Application, Material, and Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 10348
Pages: 170
Formats: report pdf report excel report power bi report ppt

3D Bioprinting Market Size (2022 to 2027)

The global 3D Bioprinting market is forecasted to grow at a CAGR of 21.2% between 2022 to 2027 and be worth USD 1724 million by 2027 from USD 543.9 million in 2022.

3D bioprinting is a process that aims at creating biomedical parts imitating the nature of tissue-like structures in the body used in the process of tissue engineering. 3D printing uses cells, biomaterials, and growth factors to fabricate these biomedical parts. layers and layers of bio-inks are used to create tissue-like structures. 3D bioprinting can be used to print organs and tissues for treatments, drug research, and transplants, and to create scaffold material used to regenerate tissues and ligaments. 

Impact of COVID-19 on the global 3D bioprinting market:

The COVID-19 pandemic leads to more R&D to counter the SARS-CoV-2 virus and find a cure in the form of vaccines and drugs for the deadly pandemic. The emergency lockdown situations lead to difficulty in obtaining much equipment, especially in the healthcare sector. The 3D bioprinting helped with this crisis. the 3D printing assisted with producing more covid-19 test swabs, respiratory devices, ventilators, and face shields, all of which were scarce during the pandemic. 

COVID-19 has accelerated the growth rate of the 3D bioprinting market.

Along with the production of equipment, the 3D printing technology helped print the lung tissues, which supported the virus's growth for researchers to study the virus better. Thus, the pandemic benefitted the market for 3D bioprinting. However, as the research activities became more focused on covid-19, the other research subjects were side-lined, and so were the issues of 3D bioprinting. In addition, ever since the impact of covid-19, it has become more critical to conduct drug testing to ensure the safety of the consumers, which has positively impacted the market.

MARKET DRIVERS:

The technological advancements drive the 3D bioprinting market along with increased research and development and government funding in the area.

The scarcity of organ donors, the rising geriatric population, and chronic diseases that need organ transplantation are driving the 3D bioprinting market growth. It was mentioned in organdonor.gov, each day 17 people die waiting for an organ transplant. Additionally, the production of medicinal equipment and several support products during the COVID-19 pandemic led the market to grow further. Furthermore, the rising acceptance and application of 3D bioprinting technologies in cosmetology and pharmaceuticals are expected to promote market growth.

The increasing demand for 3D bioprinting in the healthcare industry drives market growth.

The requirement for more complex organ transplants like heart, kidneys, and lungs are pushing the market forward. However, it is a known fact that there is a chance of the body's immune system rejecting an organ transplant when taken from another body. Still, the chances of rejection become very low when an organ transplant occurs through a 3D printing method with biomedical parts. In addition, the healthcare industry requires a 3D rating in cases of bone fractures where tissue engineering is required. Therefore, the need for the advancement of 3D printing in the healthcare industry is one of the other primary factors for the market's growth.

MARKET RESTRAINTS:

However, the complexity of the 3D bioprinting procedure and the high costs of production and management associated with the field, along with a lack of skilled and knowledgeable professionals in the study, will prove to be a hindrance to the market. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2021 to 2027

Base Year

2021

Forecast Period

2022 to 2027

Segments Covered

Based on Component, Application, Material, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global 3D Bioprinting market has been segmented and sub-segmented based on the product, end-user, and region.

3D Bioprinting Market - By Component:

  • 3D Bioprinters
    • Microextrusion bioprinting
    • Inkjet 3D Bioprinting
    • Laser-assisted Bioprinting
    • Magnetic 3D Bioprinting
    • Other technologies
  • Bioinks
    • Natural Bioinks
    • Hybrid Bioinks
    • Synthetic Bioinks

3D Bioprinting Market - By Application:

  • Research Applications
    • Drug Research
    • Regenerative Medicine
    • 3D Cell Culture
  • Clinical Application
    • Skin
    • Bone & Cartilage
    • Blood Vessels
    • Other Clinical Applications

Based on the application, the clinical application segment accounted for the leading share of the 3D bioprinting market in 2021. It is expected to expand at a growing CAGR during the forecast period. The segment is also driven by the expanding demand for pharmaceuticals and the efficient bio-drug service in this technology. 

The fastest CAGR in the market is anticipated for the tissue and organ generation sub-segment during the forecast period. The most common application of 3D bioprinting in medicine is regenerating organs and tissue suitable for transplantation. In addition, the need for tissue and organ creation is growing as the COVID-19 disease is becoming more common. Therefore, the tissue and organ generation segment is anticipated to experience exponential expansion throughout the forecast period. 

3D Bioprinting Market - By Material:

  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other Biomaterials

Based on material, the living cells segment accounted for the largest market share due to the increased R&D in this sector and rising governmental and private expenditure on research.

3D Bioprinting Market - By End User:

  • Research Organization & Academic Institutes
  • Biopharmaceuticals Companies
  • Hospital

Based on the end-user, the biopharmaceutical companies segment has a huge demand for 3D bioprinting. One of the key factors supporting the segment's growth is the increasing demand for implants for treatment and a rise in the number of chronic diseases worldwide. As a result, the segment will represent more than 45% of the market throughout the forecast period.

3D Bioprinting Market - By Region:

  • North America
  • Europe
  • Asia Pacific (APAC)
  • Latin America
  • Middle East and Africa

In 2021, the North American market had the highest global 3D printing market share and is anticipated to dominate for the entire forecast period. The market is expected to rise due to the growing adoption of IT in the healthcare sector. Around 23,369,732 active COVID-19 cases were registered in the United States until January 13th, 2021. The government is investing more in research and development to produce a vaccination for this illness. Because this technology has been recognized for use in drug testing and organ donation, there is a rising demand for 3D bioprinting. Essential market participants are obtaining licenses for 3D bioprinting, which helps the market's revenue growth.

The market in the Asia Pacific had a substantial share of the global 3D bioprinting market in 2021 and is anticipated to register the fastest CAGR during the forecast period among all the regions. However, due to the expanding number of COVID-19 cases and increased government R&D spending, Japan and China accounted for the most significant share in Asia-Pacific.  According to the WHO Report 2021, up until January 13th, 2021, China had around 87,706 active COVID-19 cases registered. Additionally, it is projected that a lack of organ donors and the rising death rate brought on by COVID-19 will further propel the 3D bioprinting industry in this area. Therefore, the Chinese government-funded building a biomaterials manufacturing facility and research into 3D printed organs and tissues. With an emphasis on pediatric 3D modeling, medical imaging, and 3D printing.

TOP COMPANIES IN THIS MARKET:

Aspect Biosystems, CELLINK, GeSiM, Bio3D Technologies Pte. Ltd., Regenovo Biotechnology Co. Ltd., Optomec Inc., GE Healthcare, ExOne (S. Kent Rockwell], Electro-Optical Systems, Renishaw ltd., Stratasys Ltd., EnvisionTEC, Cyfuse Biomedical K.K., Formlabs, Inc., Organovo Holdings Inc., and Allevi Inc. are a few of the prominent players in the global 3D bioprinting market profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

  • In 2019, Kits like the CELLINK SKIN Kit and CELLINK LIVER Kit were launched by CELLINK. Kits provide the phenotype information of tissue models, which helps the researchers produce reliable tissue models for testing cosmetic and screening drugs.
  • In 2019, Skin Bioink Kit was produced for skin patches by Allevi.
  • In 2019, To develop the 3D-bioprinting stem cell usage for treating end-stage renal diseases, Organovo collaborated with the Murdoch Children’s Research Institute and Ton Rabelink.
  • In 2019, to automatically develop the Live-cell printing processes and systems to produce the 3d live cellular structure and tissues. Digilab agreed with Orgenesis, Inc.

Please wait. . . . Your request is being processed

FAQ's

How much was the global 3D bioprinting market worth in 2021?

The global 3D bioprinting market size was valued at USD 544 million in 2021.

Which segment by application led the 3D bioprinting market?

Based on the application, the clinical application segment dominated the 3D bioprinting market in 2021.

Which region is anticipated to grow the fastest in the global 3D bioprinting market?

Geographically, the APAC regional market is predicted to register the fastest CAGR in the global market.

Which are the top players in the global 3d Bioprinting market?

Aspect Biosystems, CELLINK, GeSiM, Bio3D Technologies Pte. Ltd., Regenovo Biotechnology Co. Ltd., Optomec Inc., GE Healthcare, ExOne (S. Kent Rockwell], Electro-Optical Systems, Renishaw ltd., Stratasys Ltd., EnvisionTEC, Cyfuse Biomedical K.K., Formlabs, Inc., Organovo Holdings Inc. and Allevi Inc. are some of the notable players in the global 3D bioprinting market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample